Improved outcomes for HPV-positive head and neck cancer with cetuximab and IMRT, study suggests

Studies have shown higher survival rates for people with head and neck cancers that test positive for HPV when they are treated with systemic chemotherapy and radiation therapy. Now a new study suggests outcomes are also better when radiation therapy is combined with cetuximab, a targeted therapy.

Read the whole article on Science Daily

More from Science Daily